Text Size A A A

Active Pharmaceutical Ingredients

Tell a Friend Print Home » Products » Active Pharmaceutical Ingredients

We began producing Active Pharmaceutical Ingredients (APIs) in 1995 as a vital input in the manufacture of complex formulations and products to facilitate complete vertical integration. Today, our list of APIs exceeds 300 which is used for captive purposes as well as marketed to customers in over 60 countries across the world. We are trusted partners for many leading global generic and innovator companies. Our approach is to offer total solutions to customers by bringing to the table our successful track record, rich experience, unwavering commitment to quality, wide therapeutic range, state-of-the-art research & manufacturing capabilities, and regulatory & intellectual property (IP) expertise.

Our product list includes generics and complex APIs that require isolated manufacturing areas, like anti-cancers, peptides, steroids, sex hormones and controlled substances, including poppy-derived opiate raw materials that are primarily used in the manufacture of analgesics, sold as both Narcotic Raw Materials (NRM) and API's. We offer Bulk Actives, Intermediates and services for Custom Synthesis providing an integrated solution for the diverse requirements of generic and innovator companies. Every year, we make a large number of filings based on technology developed at our R&D centres. We manufacture APIs currently in 14 plants located in India, Hungary, the US and Israel. These manufacturing facilities have been certified as complying with Current Good Manufacturing Practices (cGMP) by several global regulatory agencies.

End- to-end support

Our comprehensive end-to-end support ensures smooth development, timely filing and successful launch of products. Our R&D prowess and manufacturing capabilities are strengthened by the presence of a strong and well-informed regulatory team. We pride in offering customers an unmatched advantage to develop and file their products in time with regulators across the globe.

We have an experienced team of IP attorneys and other skilled professionals, specialising in related fields of science and IP law, working diligently to protect our IP wealth. The team ensures that all APIs, drug products and processes developed for various global markets comply with applicable laws.

API Products Therapeutic Category/Use Pharmacopeial grade CAS No
Abiraterone acetate* Anti-Cancer PN [154229-18-2]
Acamprosate Calcium CNS Stimulant EP [77337-73-6]
Acitretin Dermatology Ph. Eur. / USP 55079-83-9
Adapalene Retinoid agent BP/EP/ USP [106685-40-9]
Adefovir Dipivoxil AntiViral In-house 142340-99-6
Alendronate Sodium Anti-Osteoporosis EP/USP [121268-17-5]
Amifostine Trihydrate* Radioprotective agent USP [112901-68-5]
Amisulpride Anti-Psychotic EP [71675-85-9]
Amorolfine Hydrochloride Dermatology In-house 78613-38-4
Amoxicillin Trihydrate Antiinfective Ph. Eur. / USP 61336-70-7
Anastrozole Anti-Cancer EP [120511-72-1]
Aripiprazole* Anti-Psychotic USP [129722-12-9]
Asenapine Maleate* Anti-Psychotic PN [65576-45-6]
Atazanavir Sulfate AntiViral In-house 229975-97-7
Atomoxetine HCl* ADHD Therapy USP [83015-26-3]
Atorvastatin Calcium Amorphous Cardiovascular In-house 134523-03-8
Atorvastatin Calcium Crystalline Cardiovascular Ph. Eur. / USP 344423-98-9
Atosiban Acetate Oxytocin Antagonist PN [90779-69-4]
Azacitidine Anti-Cancer PN [320-67-2]
Benazepril Hydrochloride Cardiovascular Ph. Eur. / USP 86541-74-4
Bendamustine* Anti-Cancer PN [16506-27-7]
Bicalutamide Anti-Androgen EP/USP [90357-06-5]
Bivalirudin* Anti-Coagulant PN [128270-60-0]
Bortezomib* Multiple Myeloma PN [179324-69-7]
Bosentan Monohydrate Cardiovascular In-house 157212-55-0
Budesonide Anti-Inlammatory Steroid EP/USP [51333-22-3]
Buprenorphine HCl Analgesic EP/USP [53152-21-9]
Bupropion HCl Anti-Depressant EP/USP [31677-93-7]
Calcipotriol Anhydrous Psoriasis BP/EP [112828-00-9]
Calcitonin (Salmon) Anti-Osteoporosis EP/USP [9007-12-9]
Candesartan cilexetil Cardiovascular Ph. Eur./ USP 145040-37-5
Capecitabine Anti-Cancer USP [154361-50-9]
Carboplatin Anti-Cancer EP/USP [41575-94-4]
Carvedilol Anti-Hypertensive EP/USP [72956-09-3]
Cefaclor Antiinfective Ph. Eur./ USP 70356-03-5
Cefdinir Antiinfective USP 91832-40-5
Cefpodoxime proxetil Antiinfective Ph. Eur. / USP 87239-81-4
Cefprozil Antiinfective USP 121123-17-9
Cefuroxime Axetil Antibiotic EP/USP [64544-07-6]
Celiprolol Hydrochloride Cardiovascular Ph. Eur. 57470-78-7
Cephalexin Antiinfective Ph. Eur./USP/BP 23325-78-2
Cilastatin sodium sterile Antiinfective Ph. Eur./ USP 81129-83-1
Cilazapril Cardiovascular Ph. Eur. 92077-78-6
Cinacalcet HCl* Calcimimetic PN [226256-56-0]
Ciprofloxacin Antiinfective Ph. Eur. / USP 85721-33-1
Ciprofloxacin Hydrochloride Antiinfective Ph. Eur. / USP 86393-32-0
Cisplatin Anti-Cancer EP/USP [15663-27-1]
Citalopram Hydrobromide CNS Ph. Eur. / USP 59729-32-7
Clarithromycin Antiinfective Ph. Eur. / USP 81103-11-9
Clarithromycin Granules 27.5% Antiinfective In-house Not Applicable
Clarithromycin Granules 43.75% Antiinfective In-house Not Applicable
Clomipramine HCl Anti-Depressant EP/USP [17321-77-6]
Clonazepam Anti-Epileptic EP/USP [1622-61-3]
Clopidogrel Bisulphate Anti-Thrombotic BP/EP/ USP [120202-66-6]
Clorazepate Dipotassium Anxiolytic USP 57109-90-7
Colesevelam* Bile acid Sequestrant PN [182815-44-7]
Dabigatran Etexilate Mesylate* Anti-Coagulant PN [872728-81-9]
Decitabine Myelodysplastic Syndrome PN [2353-33-5]
Deferasirox* Iron Chelator PN [201530-41-8]
Desloratadine Anti-Histaminic Ph. Eur. 100643-71-8
Desmopressin Acetate Vasopressin Analogue EP/USP [62288-83-9]
Desvenlafaxine Fumarate Anti-Depressant PN [313471-75-9]
Divalproex Sodium Anti-Epileptic USP [76584-70-8]
Dobutamin HCl Cardiovascular BP/EP/ USP [49745-95-1]
Donepezil HCl Anti-Alzheimer USP 884740-09-4
Doripenem Antiinfective In-house 364622-82-2
Dothiepin HCl Anti-Depressant EP [897-15-4]
Doxercalciferol* Hyperparathyroidism PN [54573-75-0]
Doxycycline Antiinfective USP 17086-28-1
Doxycycline Hyclate Antiinfective USP 24390-14-5
Dronedarone Anti-Arrhythmic PN [141626-36-0]
Drospirenone Oral Contraceptive EP/USP [67392-87-4]
Duloxetine Anti-Depressant BP/EP/ USP [136434-34-9]
Dydrogesterone Hormone Replacement Therapy BP/EP/ USP [152-62-5]
Edaravone Neuroprotective PN [89-25-8]
Emtricitabine AntiViral In-house 143491-57-0
Entecavir AntiViral In-house 209216-23-9
Epinastine HCl Anti-Histaminic EP [80012-44-8]
Epinephrine Neurotransmitter EP/USP [51-43-4]
Epoprostenol Sodium Prostaglandin PN [61849-14-7]
Eptiibatide* Anti-Thrombotic PN [188627-80-7]
Escitalopram Oxalate Anti-Depressant USP [219861-08-2]
Esomeprazole Magnesium (Amorphous) Gastrointestinal In-house 161973-10-0
Esomeprazole Sodium Proton pump inhibitor PN [161796-78-7]
Eszopiclone Hypnotic PN [138729-47-2]
Exemestane Anti-Cancer PN [107868-30-4]
Exenatide * Anti-Diabetic PN [141732-76-5]
Febuxostat Form G Antigout In-house 144060-53-7
Fesoterodine Fumarate* Overactive bladder PN [286930-03-8]
Fexofenadine Hydrochloride Antihistamine Ph. Eur/USP 153439-40-8
Finasteride Anti-Testosterone for BPH EP/USP [98319-26-7]
Fingolimod Hydrochloride* Immuno modulator PN [162359-56-0]
Flupirtine Maleate Analgesic PN [75507-68-5]
Flurbiprofen NSAID EP/JP/ USP [5104-49-4]
Fluticasone Propionate Anti-Allergic EP/USP [80474-14-2]
Fluvastatin sodium Cardiovascular Ph. Eur. 93957-55-2
Fluvoxamine Maleate Anti-Depressant EP/USP [61718-82-9]
Fosamprenavir Calcium AntiViral In-house 226700-81-8
Fosinopril sodium Cardiovascular Ph. Eur./ USP 88889-14-9
Fosphenytoin Sodium Anti-Epileptic USP [92134-98-0]
Fulvestrant Anti-Cancer EP/USP [129453-61-8]
Gabapentin Anti-Epileptic EP/USP [60142-96-3]
Galantamine Hydrobromide CNS USP/In-house 1953-04-4
Ganirelix Acetate* GnRH Antagonist PN [129311-55-3]
Gemcitabine HCl Anti-Cancer EP/USP [122111-03-9]
Granisetron HCl Anti-Emetic EP/USP [107007-99-8]
Ibandronate Sodium Anti-Osteoporosis PN [138926-19-9]
Imatinib Mesylate * Anti-Cancer PN [220127-57-1]
Imipenem Antiinfective Ph. Eur. / USP 74431-23-5
Irbesartan Cardiovascular Ph. Eur. / USP 138402-11-6
Irinotecan Anti-Cancer PN [136572-09-3]
Isotretinoin Dermatology Ph. Eur. / USP 4759-48-2
Lacosamide* Anti-Epileptic PN [175481-36-4]
Lamivudine AntiViral USP 134678-17-4
Lansoprazole Gastrointestinal Ph. Eur. 103577-45-3
Lenalidomide* Anti-Cancer PN [191732-72-6]
Lercanidipine HCl Anti-Hypertensive PN [132866-11-6]
Letrozole Anti-Cancer EP/USP [112809-51-5]
Leuprolide Acetate Anti-Cancer PN [74381-53-6]
Levalbuterol HCl Anti-Asthmatic USP [34391-04-3]
Levalbuterol Tartrate* Anti- Asthmatic PN [661464-94-4]
Levetiracetam Anti-Epileptic EP/USP [102767-28-2]
Levocetirizine di HCl Anti-Histaminic PN [130018-87-0]
Levofloxacin Antiinfective USP/JP 138199-71-0
Levosulpiride Anti-Psychotic PN [23672-07-3]
Linagliptin * Anti-Diabetic PN [668270-12-0]
Liothyronine Sodium Hormone Replacement Therapy EP/USP [6893-02-3]
Lisinopril Cardiovascular USP 83915-83-7
Lopinavir AntiViral Ph. Eur. / USP 192725-17-0
Loratadine Antihistaminic Ph. Eur. / USP 79794-75-5
Lorazepam CNS USP 846-49-1
Losartan Potassium Anti-Hypertensive EP/USP [124750-99-8]
Loteprednol Etabonate Corticosteroid PN [82034-46-6]
Lubiprostone * Laxative USP [13790-76-6]
Lurasidone HCl Schizophrenia PN [367514-87-2]
Magnesium Valproate Anti-Epileptic PN [62959-43-7]
Meloxicam NSAID EP/USP [71125-38-7]
Memantine HCl Anti-Alzheimer PN [41100-52-1]
Meropenem Antiinfective Ph. Eur./USP/JP 119478-56-7
Mesalazine/Mesalamine Anti-Inlammatory EP/USP [89-57-6]
Metadoxine Alcohol Abuse PN [74536-44-0]
Metformin HCl Anti-Diabetic EP/USP [1115-70-4]
Methyl Phenidate HCl CNS Stimulant EP [298-59-9]
Metoprolol Succinate Anti-Hypertensive EP/USP [98418-47-4]
Metoprolol Tartrate Anti-Hypertensive EP/USP [56392-17-7]
Midazolam CNS Ph. Eur. / USP 59467-70-8
Mifepristone Abortifacient PN [84371-65-3]
Milnacipran Hydrochloride CNS In-house 101152-94-7
Mirtazapine Hemihydrate Anti-Depressant EP/USP [61337-67-5]
Montelukast Sodium Anti-Asthmatic BP/EP/ USP [151767-02-1]
Naloxone HCl Opioid Antagonist EP/USP [357-08-4]
Naltrexone HCl Opioid Antagonist EP/USP [16676-29-2]
Naratriptan HCl Anti-Migraine USP [143388-64-1]
Nevirapine AntiViral Ph. Eur. / USP 129618-40-2
Octreotide Acetate Anti-Cancer PN [79517-01-4]
Ofloxacin Antiinfective Ph. Eur. / USP 82419-36-1
Olanzapine Anti-Psychotic EP/USP [132539-06-1]
Olopatadine HCl * Anti-Allergic USP [113806-05-6]
Omeprazole Magnesium CNS Ph. Eur./USP 95382-33-5
Ondansetron Base Anti-Emetic USP [116002-70-1]
Ondansetron HCl Anti-Emetic EP/USP [103639-04-9]
Orlistat Antiobesity USP/In-house 96829-58-2
Oxaliplatin Anti-Cancer EP/USP [61825-94-3]
Oxcarbazepine Anti-Epileptic EP/USP [28721-07-5]
Oxetacaine Local-Anaesthetic BP/EP [126-27-2]
Paliperidone* Anti-Psychotic PN [144598-75-4]
Pamidronate Disodium Anti-Osteoporosis EP/USP [109552-15-0]
Pantoprazole Sodium Sesquihydrate Proton pump inhibitor BP/EP/ USP [164579-32-2]
Paroxetine HCl Anti-Depressant BP/EP [78246-49-8]
Pemetrexed Disodium* Anti-Cancer EP [150399-23-8]
Pentazocine CNS In-house/IP 359-83-1
Pentoxifylline Anti-Anginal EP/USP [6493-05-6]
Phentermine HCl Appetite Suppressant USP [1197-21-3]
Pioglitazone Hydrochloride Antidiabetic Ph. Eur./ USP 112529-15-4
Pramipexole Di HCl Anti-Parkinsons EP/USP [104632-25-9]
Pramlintide Acetate Anti-Diabetic PN [196078-30-5]
Prasugrel Hydrochloride* Anti-Platelet PN [150322-43-3]
Pregabalin* Anti-Epileptic PN [148553-50-8]
Quetiapine Fumarate Anti-Psychotic PN [111974-72-2]
Quinapril Hydrochloride Cardiovascular USP 82586-55-8
Rabeprazole sodium Gastrointestinal In-house 117976-90-6
Ramipril Cardiovascular Ph. Eur. 87333-19-5
Ranitidine Hydrochloride Antihistaminic Ph. Eur. / USP 66357-59-3
Ranolazine Anti-Angina PN [142387-99-3]
Rasagiline Mesylate* Anti-Parkinsons PN [161735-79-1]
Repaglinide Antidiabetic Ph. Eur. 135062-02-1
Rifaximin Anti-bacterial EP [80621-81-4]
Riluzole Amyotrophic lateral sclerosis USP [1744-22-5]
Risedronate Sodium Anti-Osteoporosis EP/USP [115436-72-1]
Risperidone Anti-Psychotic EP/USP [106266-06-2]
Ritonavir AntiViral Ph. Eur. / USP 155213-67-5
Rivastigmine Base Anti-Parkinsons EP/USP [123441-03-2]
Rivastigmine Tartrate Anti-Parkinsons EP/USP [129101-54-8]
Rizatriptan Benzoate Anti-Histamine EP/USP [145202-66-0]
Rosuvastatin Calcium* Lipid lowering agent PN [147098-20-2]
Sertraline Hydrochloride Form I CNS Ph. Eur. 79559-97-0
Sevelamer Carbonate* Hyperphosphatemia PN [845273-93-0]
Sevelamer HCl* Hyperphosphatemia PN [152751-57-0]
Simvastatin Cardiovascular Ph. Eur. / USP 79902-63-9
Sodium Valproate Anti-Epileptic EP/USP [1069-66-5]
Solifenacin Succinate Antimuscarinic In-house 242478-38-2
Sumatriptan Succinate Anti-Migraine EP/USP [103628-48-4]
Tadalafil Others In-house 171596-29-5
Tamsulosin Hydrochloride Urology Ph. Eur./ USP 106463-17-6
Telmisartan Cardiovascular Ph. Eur./ USP 144701-48-4
Temozolomide Anti-Cancer USP [85622-93-1]
Tenofovir Disoproxil fumarate AntiViral In-house 202138-50-9
Teriparatide Anti-Osteoporosis PN [52232-67-4]
Terlipressin Acetate Vasopressin Agent PN [14636-12-5]
Testosterone Cypionate Hormone Replacement Therapy USP [58-20-8]
Tiagabine HCl Anti-Epileptic USP [145821-59-6]
Tizanidine HCl Muscle Relaxant USP [64461-82-1]
Tolterodine tartrate Antimuscarinic In-house 124937-52-6
Topiramate Anti-Epileptic USP [97240-79-4]
Tramadol HCl Opioid Analgesic EP/USP [36282-47-0]
Valacyclovir Hydrochloride AntiViral Ph. Eur. / USP 124832-27-5
Valgancyclovir Hydrochloride (Amorphous Grade) AntiViral USP 175865-59-5
Valgancyclovir Hydrochloride (Crystalline Grade) AntiViral In-House 175865-59-5
Valproic Acid Anti-Epileptic EP/USP [99-66-1]
Valsartan Cardiovascular Ph. Eur./USP 137862-53-4
Venlafaxine Hydrochloride CNS Ph. Eur. / USP 99300-78-4
Voglibose Antidiabetic JP 83480-29-9
Voriconazole Antifungal Ph. Eur. 137234-62-9
Zoledronic Acid Anti-Osteoporosis PN [118072-93-8]
Zolmitriptan Anti-Migraine PN [139264-17-8]
Zolpidem Tartrate CNS Ph. Eur./USP 99294-93-6
Zonisamide Anti-Epileptic USP [68291-97-4]

Disclaimer: Products protected under valid patents are not offered or supplied for commercial use. However, the research quantities of such products may be offered for the purpose of regulatory submissions, wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.